ETHYL 8-BROMOIMIDAZO[1,5-A]PYRIDINE-1-CARBOXYLATE, 95.0%, 250mg

tert-Butyl (R)-4-Methyl-2,2-dioxo-[1,2,3]oxathiazolidine-3-carboxylate, 95.0%, 100g

2-Methyl-2H-indazole-7-carboxylic acid, 95.0%, 25g

Tetramethylammonium fluoride tetrahydrate, 98.0%, 25g

tert-Butyldimethyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)oxy)silane, 98%, 250mg

4-Bromo-3-nitrobenzoic acid, 97.0%, 500g

1-Benzyl-N-cyclopropylpiperidin-4-amine, 97.0%, 25g

(6-(2,2,2-Trifluoroethoxy)-3-pyridinyl)boronic acid, 95.0%, 250mg

4-(4-Methoxyphenyl)oxane-4-carboxylic acid, 98+%, 1g

4,4'-Sulfonylbis(bromobenzene), 95.0%, 25g

(R)-2-Chloro-1-phenylethanol, 95.0%, 5g

1-(Triisopropylsilyl)indole>94.0%(GC)1g

4-aminobenzonitrile, min. 98%, for synthesis, 50 g, plastic packaging.